To investigate the regulatory mechanism of IGF2BP1 in t(12; 21)(p13; q22)-positive ALL, IGF2BP1 was stably knocked down in the REH cell line. This evidence concerns the gene IGF2BP1 and acute lymphoblastic leukemia.